Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif

被引:30
|
作者
Romani, Bizhan [1 ]
Engelbrecht, Susan [1 ]
Glashoff, Richard H. [1 ]
机构
[1] Univ Stellenbosch, Div Med Virol, Dept Pathol, ZA-7505 Tygerberg, South Africa
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; E3 UBIQUITIN LIGASE; CYTIDINE DEAMINASE APOBEC3G; CELL-CYCLE ARREST; ACCESSORY PROTEINS; VIRAL-RNA; SOCS-BOX; ENDOGENOUS RETROVIRUSES; ANTIRETROVIRAL ACTIVITY; REVERSE TRANSCRIPTION;
D O I
10.1007/s00705-009-0481-y
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like (APOBEC) proteins are members of a protein family sharing the common characteristic of cytidine deaminase activity. The antiviral activity of APOBEC3G and APOBEC3F has been studied more extensively than that of the other members of this family. The antiviral activity of APOBEC3B and APOBEC3DE has also been described. Studies of other APOBEC proteins have not revealed any antiviral activities against HIV-1; however, further investigation is required. In the absence of human immunodeficiency virus type 1 (HIV-1) virion infectivity factor (Vif), APOBEC3G and APOBEC3F are incorporated into HIV-1 virions and hypermutate the viral genomic DNA by their cytidine deaminase activity. HIV-1 Vif protein suppresses the antiviral role of APOBEC proteins by several mechanisms that lead to inhibition of incorporation of APOBEC3G/3F into HIV-1 virions. The detailed mechanisms involved in the suppression of APOBEC proteins by Vif are still being elucidated. Novel studies in which as yet undefined aspects of the suppression of APOBEC proteins are investigated could reveal important and potentially exploitable information for addressing HIV-1 infection in humans.
引用
收藏
页码:1579 / 1588
页数:10
相关论文
共 50 条
  • [21] Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F
    Nagao, Tamiko
    Yamashita, Tomoki
    Miyake, Ariko
    Uchiyama, Tsuneo
    Nomaguchi, Masako
    Adachi, Akio
    JOURNAL OF MEDICAL INVESTIGATION, 2010, 57 (1-2): : 89 - 94
  • [22] A Conserved uORF Regulates APOBEC3G Translation and Is Targeted by HIV-1 Vif Protein to Repress the Antiviral Factor
    Libre, Camille
    Seissler, Tanja
    Guerrero, Santiago
    Batisse, Julien
    Verriez, Cedric
    Stupfler, Benjamin
    Gilmer, Orian
    Cabrera-Rodriguez, Romina
    Weber, Melanie M.
    Valenzuela-Fernandez, Agustin
    Cimarelli, Andrea
    Etienne, Lucie
    Marquet, Roland
    Paillart, Jean-Christophe
    BIOMEDICINES, 2022, 10 (01)
  • [23] HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
    Stopak, K
    de Noronha, C
    Yonemoto, W
    Greene, WC
    MOLECULAR CELL, 2003, 12 (03) : 591 - 601
  • [24] Loop 1 of APOBEC3C Regulates its Antiviral Activity against HIV-1
    Vasudevan, Ananda Ayyappan Jaguva
    Balakrishnan, Kannan
    Gertzen, Christoph G. W.
    Borveto, Fanni
    Zhang, Zeli
    Sangwiman, Anucha
    Held, Ulrike
    Kuestermann, Caroline
    Banerjee, Sharmistha
    Schumann, Gerald G.
    Haeussinger, Dieter
    Bravo, Ignacio G.
    Gohlke, Holger
    Muenk, Carsten
    JOURNAL OF MOLECULAR BIOLOGY, 2020, 432 (23) : 6200 - 6227
  • [25] A high throughput HIV-1 full replication assay that includes HIV-1 Vif as an antiviral target
    Cao, Joan
    Isaacson, Jason
    Patick, Amy
    Blair, Wade
    ANTIVIRAL RESEARCH, 2007, 74 (03) : A64 - A65
  • [26] Inhibition of ATM-directed antiviral responses by HIV-1 Vif
    Wong, Hoi Tong
    Luperchio, Adeline M.
    Riley, Sean
    Salamango, Daniel J.
    PLOS PATHOGENS, 2023, 19 (09)
  • [27] Differential Anti-APOBEC3G Activity of HIV-1 Vif Proteins Derived from Different Subtypes
    Iwabu, Yukie
    Kinomoto, Masanobu
    Tatsumi, Masashi
    Fujita, Hideaki
    Shimura, Mari
    Tanaka, Yoshitaka
    Ishizaka, Yukihito
    Nolan, David
    Mallal, Simon
    Sata, Tetsutaro
    Tokunaga, Kenzo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (46) : 35350 - 35358
  • [28] Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1
    Luo, Dan
    Luo, Ronghua
    Wang, Weilin
    Deng, Rui
    Wang, Shirui
    Ma, Xinyu
    Pu, Chunlan
    Liu, Yuanyuan
    Zhang, Hongjia
    Yu, Su
    Huang, Qing
    Yang, Liumeng
    Tong, Yu
    Zheng, Yongtang
    Li, Rui
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 111
  • [29] Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes
    Reddy, Kavidha
    Ooms, Marcel
    Letko, Michael
    Garrett, Nigel
    Simon, Viviana
    Ndung'u, Thumbi
    AIDS, 2016, 30 (11) : 1723 - 1729
  • [30] Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions
    Azimi, Farshad C.
    Lee, Jeffrey E.
    PROTEIN SCIENCE, 2020, 29 (02) : 391 - 406